Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
December 31, 2007
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2008
Conditions
Healthy
Interventions
DRUG
RO-14
Trial Locations (1)
Unknown
Hospital Santa Creu i Sant Pau, Barcelona
All Listed Sponsors
lead
Rovi Pharmaceuticals Laboratories
INDUSTRY
NCT00629733 - Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers | Biotech Hunter | Biotech Hunter